Gland Pharma's Rs 6,500-crore Initial Public Offer (IPO) will open for subscription on Monday. According to Bloomberg, it is the largest IPO brought by any pharmaceutical company in India. Prior to this IPO, Gland Pharma has been appointed by the Government of Singapore, Nomura, Goldman Sachs.It has raised Rs 1,944 crore through anchor investors such as Morgan Stanley, SBI Mutual Fund and Axis Mutual Fund. The company has raised these funds at the rate of Rs 1,500 per equity share. This IPO will be subscribed till Wednesday.

Let's know what is the price band of IPO and other things
The company has fixed a price of Rs 1,490-1,500 per share for this IPO. Under this IPO, shares
worth Rs 1,250 crore (80 lakh shares) will be issued. At the same time, 3.48 crore shares will
be offered through the offer of sale. The proceeds from this IPO can be used for working capital,
capital expenditure and general expenses related to the company Can be done for The company has prepared a lot of 15 shares. This means that any investor must buy at least 15 shares. In this IPO, 35 percent shares have been reserved for the retail category.

Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Hatung Securities India Private Limited and Nomura Financial Advisory & Securities (India) Limited are managing the Gland Pharma IPO.

Hyderabad-based Gland Pharma was established in the year 1978. The company has a presence in around 60 countries. The company has seven manufacturing units in India.
In 2017, Fosun Pharma of China acquired 74% stake in the company After this IPO,the promoters' stake in the company will be reduced from 74 percent to 58 percent.